Skip to main content
Premium Trial:

Request an Annual Quote

MediChem, Rigel Pen Structural Proteomics Deal

NEW YORK, Sept. 6 – MediChem and Rigel Pharmaceuticals announced a two-year structural proteomics collaboration to search for new treatments in the area of ubiquitin ligases, which are involved in cell division and the progression of some cancers.

Under the terms of the deal, MediChem's Emerald BioStructures structural proteomics unit will express, purify, and crystallize proteins that Rigel is focusing on in its oncology program. 

"Ubiquitin ligase activity has become a very important and promising area of discovery research for cancer therapeutics," Donald Payan, chief scientific officer for Rigel, said in a statement released Wednesday.

"The structural information that we gain through our collaboration with MediChem will have a significant impact on the outcome of our drug discovery programs," he added. 

Rigel will pay MediChem for research it conducts and will also provide milestone payments for completion of specified scientific achievements. Rigel will retain rights to certain technology, data, and improvements to MediChem's structural proteomics technology platform.

Rigel of South San Francisco, Calif., will also grant Chicago-based MediChem a right of discussion on all future medicinal chemistry partnering opportunities as related to the targets researched during this collaboration. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.